1. Antihypertensives/dobutamine/tozinameran

   Case report 19 March 2022 Pages: 51 - 51

2. Antineoplastics

   Case report 19 March 2022 Pages: 52 - 52

3. Antineoplastics

   Case report 19 March 2022 Pages: 53 - 53

4. Antineoplastics

   Case report 19 March 2022 Pages: 54 - 54

5. Antineoplastics

   Case report 19 March 2022 Pages: 55 - 55

6. Antineoplastics

   Case report 19 March 2022 Pages: 56 - 56

7. Antineoplastics

   Case report 19 March 2022 Pages: 57 - 57

8. Antineoplastics

   Case report 19 March 2022 Pages: 58 - 58

9. Antineoplastics

   Case report 19 March 2022 Pages: 59 - 59

10. Antineoplastics

    Case report 19 March 2022 Pages: 60 - 60

11. Antineoplastics

    Case report 19 March 2022 Pages: 61 - 61

12. Antineoplastics

    Case report 19 March 2022 Pages: 62 - 62

13. Antineoplastics/immunosuppressants

    Case report 19 March 2022 Pages: 63 - 63

14. Antipsychotics

    Case report 19 March 2022 Pages: 64 - 64

15. Antipsychotics/diazepam

    Case report 19 March 2022 Pages: 65 - 65

16. Antiretrovirals

    Case report 19 March 2022 Pages: 66 - 66

17. Antirheumatics

    Case report 19 March 2022 Pages: 67 - 67

18. Antithymocyte-globulin/ciclosporin

    Case report 19 March 2022 Pages: 68 - 68

19. Antituberculars

    Case report 19 March 2022 Pages: 69 - 69

20. Apixaban

    Case report 19 March 2022 Pages: 70 - 70

21. Apremilast

    Case report 19 March 2022 Pages: 71 - 71

22. Aspirin/clopidogrel

    Case report 19 March 2022 Pages: 72 - 72

23. Aspirin/clopidogrel/argatroban

    Case report 19 March 2022 Pages: 73 - 73

24. Aspirin/clopidogrel/unspecified anticoagulants

    Case report 19 March 2022 Pages: 74 - 74

25. Aspirin/dabigatran-etexilate/rivaroxaban

    Case report 19 March 2022 Pages: 75 - 75

26. Aspirin/enoxaparin sodium

    Case report 19 March 2022 Pages: 76 - 76

27. Atezolizumab

    Case report 19 March 2022 Pages: 77 - 77

28. Atezolizumab

    Case report 19 March 2022 Pages: 78 - 78

29. Atezolizumab

    Case report 19 March 2022 Pages: 79 - 79

30. Atezolizumab/paclitaxel

    Case report 19 March 2022 Pages: 80 - 80

31. Atorvastatin/hydrochlorothiazide

    Case report 19 March 2022 Pages: 81 - 81

32. Atorvastatin/warfarin interaction

    Case report 19 March 2022 Pages: 82 - 82

33. Atropine/pramipexole

    Case report 19 March 2022 Pages: 83 - 83

34. Avapritinib

    Case report 19 March 2022 Pages: 84 - 84

35. Axitinib/sunitinib

    Case report 19 March 2022 Pages: 85 - 85

36. Azacitidine/venetoclax

    Case report 19 March 2022 Pages: 86 - 86

37. Azathioprine

    Case report 19 March 2022 Pages: 87 - 87

38. AZD-1222

    Case report 19 March 2022 Pages: 88 - 88

39. Azd-1222

    Case report 19 March 2022 Pages: 89 - 89

40. AZD-1222

    Case report 19 March 2022 Pages: 90 - 90

41. AZD-1222

    Case report 19 March 2022 Pages: 91 - 91

42. AZD-1222

    Case report 19 March 2022 Pages: 92 - 92

43. AZD-1222

    Case report 19 March 2022 Pages: 93 - 93

44. AZD-1222

    Case report 19 March 2022 Pages: 94 - 94

45. AZD-1222

    Case report 19 March 2022 Pages: 95 - 95

46. AZD-1222

    Case report 19 March 2022 Pages: 96 - 96

47. AZD-1222

    Case report 19 March 2022 Pages: 97 - 97

48. Azd-1222

    Case report 19 March 2022 Pages: 98 - 98

49. Azd-1222

    Case report 19 March 2022 Pages: 99 - 99

50. AZD-1222/methylprednisolone

    Case report 19 March 2022 Pages: 100 - 100